文献速递新生儿儿童感染儿童心血管与肾脏

新生儿疑似或确诊单纯疱疹病毒感染静脉阿昔洛韦治疗期间急性肾损伤

Acute Kidney Injury During Treatment with Intravenous Acyclovir for Suspected or Confirmed Neonatal Herpes Simplex Virus Infection.
PubMed 文献 · J Pediatr · 2020-02-06

Cox回归显示确诊单纯疱疹病毒病、同时使用至少2种肾毒性药物、接受机械通气和入住重症监护室是AKI的危险因素;作者结论认为该队列AKI发生率低,但病情更重及合并其他肾毒性药物暴露的婴儿风险更高,需要更密切监测。

要点

  • 确诊单纯疱疹病毒病、≥2种合并肾毒性药物、机械通气、入住ICU与AKI风险升高相关。
  • 病情更重或合并其他肾毒性药物暴露的婴儿需更密切监测肾功能。

核心结论

  • 在接受静脉阿昔洛韦治疗的婴儿队列中AKI发生率低,但病情更重及合并其他肾毒性药物暴露者风险更高,需更密切监测。

主要发现

  • Cox回归显示确诊单纯疱疹病毒病(OR,4.35;P=.002)、接受≥2种合并肾毒性药物(OR,3.07;P=.004)、接受机械通气(OR,5.97;P=.001)、入住重症监护室(OR,6.02;P=.006)为AKI危险因素。
  • 多数婴儿接受短疗程阿昔洛韦(中位数5剂)。

关键数值与推荐

  • AKI依据已发表的新生儿AKI标准按肌酐变化分类。
  • 队列AKI发生率5.6%,发生率为每1000个阿昔洛韦治疗日11.6例。
  • 确诊单纯疱疹病毒病OR 4.35(P=.002);≥2种合并肾毒性药物OR 3.07(P=.004);机械通气OR 5.97(P=.001);入住ICU OR 6.02(P=.006)。

临床怎么用

  • 对接受静脉阿昔洛韦的新生儿,尤其确诊单纯疱疹病毒病、合并≥2种肾毒性药物、机械通气或入住ICU者,应更密切监测肾功能。

局限性

  • 为回顾性队列研究,仅纳入基线与治疗期间均测血清肌酐的婴儿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the epidemiology of and risk factors associated with acute kidney injury (AKI) during acyclovir treatment in neonates and infants. STUDY DESIGN: We conducted a multicenter (n = 4), retrospective cohort study of all hospitalized infants age <60 days treated with intravenous acyclovir (≥1 dose) for suspected or confirmed neonatal herpes simplex virus disease from January 2011 to December 2015. Infants with serum creatinine measured both before acyclovir (baseline) and during treatment were included. We classified AKI based on changes in creatinine according to published neonatal AKI criteria and performed Cox regression analysis to evaluate risk factors for AKI during acyclovir treatment. RESULTS: We included 1017 infants. The majority received short courses of acyclovir (median, 5 doses). Fifty-seven infants (5.6%) developed AKI during acyclovir treatment, with an incidence rate of AKI at 11.6 per 1000 acyclovir days. Cox regression analysis identified having confirmed herpes simplex virus disease (OR, 4.35; P = .002), receipt of ≥2 concomitant nephrotoxic medications (OR, 3.07; P = .004), receipt of mechanical ventilation (OR, 5.97; P = .001), and admission to an intensive care unit (OR, 6.02; P = .006) as risk factors for AKI during acyclovir treatment. CONCLUSIONS: Among our cohort of infants exposed to acyclovir, the rate of AKI was low. Sicker infants and those exposed to additional nephrotoxic medications seem to be at greater risk for acyclovir-induced toxicity and warrant closer monitoring.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Downes KJ, Boge CLK, Baro E, et al. Acute Kidney Injury During Treatment with Intravenous Acyclovir for Suspected or Confirmed Neonatal Herpes Simplex Virus Infection. J Pediatr. 2020. PMID: 32037154. doi:10.1016/j.jpeds.2019.12.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。